Thomas Kornecook

442 total citations
8 papers, 90 citations indexed

About

Thomas Kornecook is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Thomas Kornecook has authored 8 papers receiving a total of 90 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pharmacology and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Thomas Kornecook's work include Ion channel regulation and function (3 papers), Neuroscience and Neuropharmacology Research (2 papers) and Receptor Mechanisms and Signaling (2 papers). Thomas Kornecook is often cited by papers focused on Ion channel regulation and function (3 papers), Neuroscience and Neuropharmacology Research (2 papers) and Receptor Mechanisms and Signaling (2 papers). Thomas Kornecook collaborates with scholars based in United States and Switzerland. Thomas Kornecook's co-authors include Jean‐Cosme Dodart, Gregory M. Dillon, Jacob Marcus, Delia S. Shelton, Ruey-Ruey C. Huang, Blake A. Rowe, Xiaoshan Min, Justin K. Murray, Shanti M. Amagasu and Les P. Miranda and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Behavioural Brain Research.

In The Last Decade

Thomas Kornecook

8 papers receiving 89 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Kornecook United States 5 44 38 29 19 15 8 90
Cecilia Cannarozzo Finland 6 26 0.6× 45 1.2× 16 0.6× 11 0.6× 14 0.9× 7 86
Francisca Julio‐Kalajzić France 7 43 1.0× 53 1.4× 15 0.5× 21 1.1× 32 2.1× 14 122
Daniel Almeida da Silva e Silva Brazil 7 51 1.2× 67 1.8× 27 0.9× 25 1.3× 6 0.4× 13 149
Caroline Brandão‐Teles Brazil 7 58 1.3× 18 0.5× 21 0.7× 11 0.6× 9 0.6× 13 142
Holly M. Robb United States 6 93 2.1× 37 1.0× 33 1.1× 28 1.5× 36 2.4× 10 161
Meng Yu United States 6 20 0.5× 29 0.8× 33 1.1× 22 1.2× 8 0.5× 10 126
Yasmine Sherafat United States 6 72 1.6× 55 1.4× 25 0.9× 22 1.2× 20 1.3× 6 118
Iboro C. Umana United States 3 84 1.9× 41 1.1× 47 1.6× 7 0.4× 25 1.7× 3 137
Hilda Solanoy Singapore 3 68 1.5× 54 1.4× 34 1.2× 11 0.6× 14 0.9× 3 138
Sayuri Ishiwata Japan 8 67 1.5× 68 1.8× 15 0.5× 7 0.4× 13 0.9× 12 153

Countries citing papers authored by Thomas Kornecook

Since Specialization
Citations

This map shows the geographic impact of Thomas Kornecook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Kornecook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Kornecook more than expected).

Fields of papers citing papers by Thomas Kornecook

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Kornecook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Kornecook. The network helps show where Thomas Kornecook may publish in the future.

Co-authorship network of co-authors of Thomas Kornecook

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Kornecook. A scholar is included among the top collaborators of Thomas Kornecook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Kornecook. Thomas Kornecook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Radl, Daniela, Thomas Kornecook, Jack Bergman, et al.. (2025). Environmental determinants of ketamine’s prohedonic and antianhedonic efficacy: Persistence of enhanced reward responsiveness is modulated by chronic stress. Journal of Pharmacology and Experimental Therapeutics. 392(5). 103572–103572. 2 indexed citations
2.
Milgram, Benjamin C., R. Foti, Thomas Kornecook, et al.. (2022). Discovery of pyridyl urea sulfonamide inhibitors of NaV1.7. Bioorganic & Medicinal Chemistry Letters. 73. 128892–128892. 1 indexed citations
3.
Meyer, James, Brian A. Sparling, William J. McCarty, et al.. (2019). Pharmacological Assessment of Sepiapterin Reductase Inhibition on Tactile Response in the Rat. Journal of Pharmacology and Experimental Therapeutics. 371(2). 476–486. 5 indexed citations
4.
Wu, Bin, Justin K. Murray, Kristin L. Andrews, et al.. (2018). Discovery of Tarantula Venom-Derived NaV1.7-Inhibitory JzTx-V Peptide 5-Br-Trp24 Analogue AM-6120 with Systemic Block of Histamine-Induced Pruritis. Journal of Medicinal Chemistry. 61(21). 9500–9512. 17 indexed citations
5.
Sparling, Brian A., Jessica Able, Howard Bregman, et al.. (2016). Discovery and hit-to-lead evaluation of piperazine amides as selective, state-dependent NaV1.7 inhibitors. MedChemComm. 8(4). 744–754. 4 indexed citations
6.
Dillon, Gregory M., Laura S. Lubbers, Julie Lao, et al.. (2011). MK-7128, a novel CB1 receptor inverse agonist, improves scopolamine-induced learning and memory deficits in mice. Behavioural Pharmacology. 22(2). 91–100. 9 indexed citations
7.
Dillon, Gregory M., et al.. (2009). Prefrontal cortex lesions and scopolamine impair attention performance of C57BL/6 mice in a novel 2-choice visual discrimination task. Behavioural Brain Research. 204(1). 67–76. 26 indexed citations
8.
Kornecook, Thomas, et al.. (2009). Isoform‐specific effects of apolipoprotein E on cognitive performance in targeted‐replacement mice overexpressing human APP. Genes Brain & Behavior. 9(2). 182–192. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026